This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dimitroff, C. J. Articles by Rubin, M. A. Search for Related Content PubMed PubMed Citation Articles by Dimitroff, C. J. Articles by Rubin, M. A.

Identification of Leukocyte E-Selectin Ligands, P-Selectin Glycoprotein Ligand-1 and E-Selectin Ligand-1, on Human Metastatic Prostate Tumor Cells

¹ Harvard Skin Disease Research Center, Department of Dermatology, and ² Department of Pathology, Brigham and Women's Hospital; ³ Harvard Medical School, Boston, Massachusetts; and ⁴ Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan

Requests for reprints: Charles J. Dimitroff, Harvard Institutes of Medicine, Room 650, 77 Avenue Louis Pasteur, Boston, MA 02115. Phone: 617-525-5693; Fax: 617-525-5571; E-mail: cdimitroff{at}rics.bwh.harvard.edu.

Prostate tumor cells, which characteristically metastasize to bone, initiate binding interactions with bone marrow endothelium under blood flow conditions through binding interactions with E-selectin. We hypothesized that E-selectin ligands on prostate tumor cells are directly associated with bone-metastatic potential. In this report, we elucidate the identity of E-selectin ligands on human metastatic prostate tumor cells and examine their association with prostate tumor progression and metastasis in vivo. To our surprise, we found that the E-selectin-binding form of P-selectin glycoprotein ligand-1 (PSGL-1) is expressed on the human bone-metastatic prostate tumor MDA PCa 2b cell line. Interestingly, we also found that human prostate tumor cells derived from bone, lymph node, and brain metastases expressed another leukocyte E-selectin ligand, E-selectin ligand-1 (ESL-1). Immunohistochemical analysis of PSGL-1 and ESL-1 in normal prostate tissue and in localized and metastatic prostate tumors revealed that ESL-1 was principally localized to intracellular cell membrane and expressed on all normal and malignant prostate tissue, whereas PSGL-1 was notably detected on the surfaces of bone-metastatic prostate tumor cells. These findings implicate a functional role of PSGL-1 in the bone tropism of prostate tumor cells and establish a new perspective into the molecular mechanism of human prostate tumor metastasis.

This article has been cited by other articles:

				S. R. Barthel, G. K. Wiese, J. Cho, M. J. Opperman, D. L. Hays, J. Siddiqui, K. J. Pienta, B. Furie, and C. J. Dimitroff Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking PNAS, November 17, 2009; 106(46): 19491 - 19496. [Abstract] [Full Text] [PDF]

				S. R Barthel, J. D Gavino, G. K Wiese, J. M Jaynes, J. Siddiqui, and C. J Dimitroff Analysis of glycosyltransferase expression in metastatic prostate cancer cells capable of rolling activity on microvascular endothelial (E)-selectin Glycobiology, October 1, 2008; 18(10): 806 - 817. [Abstract] [Full Text] [PDF]

				G. J. Strewler Cancer Stem Cells and Bone Metastasis IBMS BoneKEy, September 1, 2008; 5(9): 308 - 322. [Abstract] [Full Text] [PDF]

				M. E. Gainers, L. Descheny, S. R. Barthel, L. Liu, M.-A. Wurbel, and C. J. Dimitroff Skin-Homing Receptors on Effector Leukocytes Are Differentially Sensitive to Glyco-Metabolic Antagonism in Allergic Contact Dermatitis J. Immunol., December 15, 2007; 179(12): 8509 - 8518. [Abstract] [Full Text] [PDF]

				R. R. Langley and I. J. Fidler Tumor Cell-Organ Microenvironment Interactions in the Pathogenesis of Cancer Metastasis Endocr. Rev., May 1, 2007; 28(3): 297 - 321. [Abstract] [Full Text] [PDF]

				S. Gout, C. Morin, F. Houle, and J. Huot Death Receptor-3, a New E-Selectin Counter-Receptor that Confers Migration and Survival Advantages to Colon Carcinoma Cells by Triggering p38 and ERK MAPK Activation. Cancer Res., September 15, 2006; 66(18): 9117 - 9124. [Abstract] [Full Text] [PDF]

				J. Holgersson and J. Lofling Glycosyltransferases involved in type 1 chain and Lewis antigen biosynthesis exhibit glycan and core chain specificity Glycobiology, July 1, 2006; 16(7): 584 - 593. [Abstract] [Full Text] [PDF]

				G. J. Strewler The Stem Cell Niche and Bone Metastasis IBMS BoneKEy, May 1, 2006; 3(5): 19 - 29. [Abstract] [Full Text] [PDF]

				C. J. Dimitroff Sharing the Same Vascular Addressins for Osteotropic Behavior of Hematopoietic Progenitor Cells and Cancer IBMS BoneKEy, October 1, 2005; 2(10): 16 - 19. [Full Text] [PDF]